FDA recall, , High risk
MediNatura ReBoost and ClearLife Nasal Sprays
ReBoost Nasal Spray and ClearLife Allergy Nasal Spray contain yeast, mold, and microbial contamination.
Summary by Recall Canary from the FDA notice
What happened
Medinatura New Mexico, inc., of Albuquerque, New Mexico, recalled ClearLife Allergy Nasal Spray and ReBoost Nasal Spray because the products were found to contain yeast, mold, and microbial contamination identified as Achromobacter. The recall began on December 12, 2025, and the products were distributed nationwide in the US.
2 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is your bottle affected?
2 products
Compare the details below with your product and check the FDA notice to confirm whether it is affected.
A UPC is the number printed under a barcode. An NDC (National Drug Code) is usually printed on the drug's label.
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles
- NDC or UPC
- NDC 62795-4006-9
- UPC 787647101887
- Lot code
- All lots within expiry.
ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles
- NDC or UPC
- NDC 62795-4005-9
- UPC 787647101863
- Lot code
- All lots within expiry.
Recall details
- Company began the recall
- Sold in
Nationwide in the US
- Company
- Medinatura New Mexico, inc.Albuquerque, New Mexico
- Hazard
- Contamination
- Risk
High risk
There is a reasonable chance that taking it could cause serious health problems or death.
FDA Class I recall · How risk is rated
- Event ID
- 98095
- Recall numbers
- D-0288-2026 to D-0289-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
In FDA's weekly enforcement report
Classified by FDA
Listed on Recall Canary
